This just in, from a Google alert sent by email:
*****************************************************************
ZURICH -(Dow Jones)- Novartis AG (NVS) chief operating officer Joerg Reinhardt said Wednesday Novartis plans to file experimental multiple sclerosis pill FTY720 for regulatory approval before the end of this year.
Reinhardt was speaking at a press conference to detail the pharmaceutical company's fourth-quarter earnings.
Company Web site: www.novartis.com
-By Anita Greil, Dow Jones Newswires; +41 43 443 8044 ; anita.greil@ dowjones.com
(END) Dow Jones Newswires 01-28-09 0426ET
Copyright (c) 2009 Dow Jones & Company, Inc.
So, the GREAT news is the drug will be submitted for approval by the end of this year...
The news that is between those lines is that my free drug ride may be ending sooner that I hoped.
Don't get me wrong -- I'm thrilled that the MS population will be able to finally have a pill added to their choice of CRABs, but I don't know where I'm going to get the money to pay for this stuff when they start charging. As soon as it gets approved, I've got to fork over money for the stuff. I'm uninsured and don't qualify for Medicaid...what am I going to do??
I sure wish part of the agreement to enter the clinical trial had been "free medication for life". Would it really have put that big a dent in Novartis' pocket to take care of us guinea pigs who so graciously allowed the experiment to proceed to the point at which their cash cow will be ready for milking??